Clinical trials
Phase 2 Idiopathic Pulmonary Fibrosis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
134 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 2 |
| 2002 | 1 |
| 2003 | 2 |
| 2004 | 1 |
| 2005 | 1 |
| 2007 | 1 |
| 2008 | 3 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 6 |
| 2012 | 5 |
| 2013 | 5 |
| 2014 | 5 |
| 2015 | 5 |
| 2016 | 6 |
| 2017 | 3 |
| 2018 | 4 |
| 2019 | 4 |
| 2020 | 9 |
| 2021 | 3 |
| 2022 | 12 |
| 2023 | 12 |
| 2024 | 10 |
| 2025 | 13 |
| 2026 | 15 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 65 |
| Recruiting | 19 |
| Terminated | 17 |
| Active, not recruiting | 12 |
| Withdrawn | 8 |
| Not yet recruiting | 7 |
| Unknown status | 6 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Boehringer Ingelheim | 6 |
| Hoffmann-La Roche | 5 |
| Novartis Pharmaceuticals | 4 |
| Pliant Therapeutics, Inc. | 4 |
| Actelion | 3 |
| Biogen | 3 |
| Haisco Pharmaceutical Group Co., Ltd. | 3 |
| University of Alabama at Birmingham | 3 |
| Afferent Pharmaceuticals, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2 |
| AstraZeneca | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Idiopathic Pulmonary Fibrosis | 134 |
| Pulmonary Fibrosis | 31 |
| Lung Diseases, Interstitial | 16 |
| Fibrosis | 12 |
| Lung Diseases | 7 |
| Cough | 6 |
| Idiopathic Interstitial Pneumonias | 6 |
| Hypertension, Pulmonary | 5 |
| Respiratory Tract Diseases | 5 |
| Pulmonary Arterial Hypertension | 4 |
Trials
Showing 26 to 50 of 134. Each trial links to its page on Pharma Observatory.
34 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.